SRPT - Sarepta Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.92
52-Week Change 39.87%
S&P500 52-Week Change 3N/A
52 Week High 3172.70
52 Week Low 372.05
50-Day Moving Average 3155.86
200-Day Moving Average 3126.26

Share Statistics

Avg Vol (3 month) 3956.8k
Avg Vol (10 day) 3858.55k
Shares Outstanding 577.99M
Float 74.16M
% Held by Insiders 14.82%
% Held by Institutions 195.52%
Shares Short (Jun 14, 2020) 411.83M
Short Ratio (Jun 14, 2020) 410.94
Short % of Float (Jun 14, 2020) 417.97%
Short % of Shares Outstanding (Jun 14, 2020) 415.17%
Shares Short (prior month May 14, 2020) 411.56M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 11, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020


Profit Margin -160.96%
Operating Margin (ttm)-138.35%

Management Effectiveness

Return on Assets (ttm)-14.35%
Return on Equity (ttm)-52.61%

Income Statement

Revenue (ttm)407.5M
Revenue Per Share (ttm)5.45
Quarterly Revenue Growth (yoy)30.60%
Gross Profit (ttm)-236.46M
EBITDA -532.02M
Net Income Avi to Common (ttm)-655.92M
Diluted EPS (ttm)-8.77
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.17B
Total Cash Per Share (mrq)27.84
Total Debt (mrq)765.68M
Total Debt/Equity (mrq)66.88
Current Ratio (mrq)8.31
Book Value Per Share (mrq)14.69

Cash Flow Statement

Operating Cash Flow (ttm)317.56M
Levered Free Cash Flow (ttm)-131.52M